Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Latest news

4/5/2018 New Database: Pharmaceutical Drug Import to Russia from EEU Countries

In 2011, the post-Soviet countries started to build a single customs zone. As a result, the transport control was placed on the external borders of the member countries, and the domestic transportation of products became untraceable. In 2017, Russia imported 8.4 bln RUB worth of pharmaceutical drugs manufactured in the EEU countries (wholesale prices), which is in monetary terms 9.1% higher than that of 2016. In physical terms, Russia imported nearly 212 mln units of drugs, which is 3.5% lower than that of 2016.

4/2/2018 Database Update: API Import to Russia (January 2018)

In January 2018, Russia imported 4.7 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms 7% lower than that of January 2017. In physical terms, Russia imported nearly 860 tons of APIs, which is 18% higher than that of January 2017.

3/30/2018 Database Update: Import of Veterinary Drugs, Feed, Feed Supplements and APIs to Russia (January 2018)

In January 2018, Russia imported 1.9 bln RUB worth of feed supplements (free circulation prices), which is in monetary terms 13% lower than that of January 2017, 1.3 bln RUB worth of veterinary drugs, which is 3% higher than that of January 2017, and 200 mln RUB worth of veterinary APIs, which is as much as 62% higher than that of January 2017.

3/29/2018 Database Update: Pharmaceutical Drug Import to Russia (January 2018)

In January 2018, Russia imported 30.6 bln RUB worth of ready-made drugs (free circulation prices), which is in monetary terms 1.5% higher than that of January 2017, and 6.5 bln RUB worth of in-bulk drugs, which is 4.4% lower than that of January 2017.

3/26/2018 RNC Pharma Database Update: Pharmaceutical Drug Production in Russia (February 2018)

Between January and February 2018, Russian manufacturers dispatched 46.9 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms 1.3% lower than that of the same period of 2017. In physical terms, Russia produced nearly 670 units of drugs, which is 4.9% lower than that of the same period of 2017. The production of over-the-counter drugs has fallen by 9.5%, while the Rx category has a 3.8% growth.

All news [82]

Our competences

RNC Pharma is focused on providing information about development trends of Russian pharmaceutical market infrastructure component. Our experts also provide services on strategic marketing, such as forecasting, business planning, etc.